Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
Mitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specifi...
Main Authors: | Idit Yedidya, Aniek L. van Wijngaarden, Nina Ajmone Marsan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/8/1/2 |
Similar Items
-
Mitral Valve Prolapse and Mitral Annular Disjunction Arrhythmic Syndromes: Diagnosis, Risk Stratification and Management
by: Panagioula Niarchou, et al.
Published: (2022-09-01) -
Arrhythmic Mitral Valve Prolapse: New Menaces of the Known Disease
by: D. A. Kuzhel, et al.
Published: (2023-03-01) -
Mitral valve prolapse syndrome
by: Miłosz Sanecki, et al.
Published: (2024-01-01) -
Echocardiographic Parameters to Predict Malignant Events in Arrhythmic Mitral Valve Prolapse Population
by: Alessandro Vairo, et al.
Published: (2023-02-01) -
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment
by: Paolo Compagnucci, et al.
Published: (2024-02-01)